Zdrowie i gospodarka · 01/09/1999

FDA Releases Draft Guidance on Accelerated Approval of Antiretroviral Drugs Using Plasma HIV RNA Measurements

The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies develop antiretroviral drugs and facilitate discussion among the agency, industry, and scientific communities about the use of plasma HIV RNA measurements in clinical trials.